- Home
- / Protea Biosciences Group
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Protea Biosciences Group financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2020-04-27
Market Capitalization
$794
2020-04-27
Revenue
$2.4 M
FY, 2016
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|---|---|
| Revenue | 713.0K | 834.3K | 1.2M | 1.8M | 2.0M | 2.4M |
| Revenue growth, % | 44.5% | 13.3% | 22.1% | |||
| Cost of goods sold | 871.9K | 721.7K | 1.7M | |||
| Gross profit | 896.4K | 1.3M | 741.0K | |||
| Gross profit margin, % | 50.7% | 64.0% | 30.3% | |||
| General and administrative expense | 5.2M | 5.2M | ||||
| Operating expense total | 11.5M | 9.8M | 11.6M | 8.4M | 6.2M | |
| EBIT | (10.8M) | (9.0M) | (10.3M) | (10.7M) | (7.1M) | (5.5M) |
| EBIT margin, % | -1511.3% | -1076.5% | -843.9% | -604.7% | -356.4% | -224.5% |
| Investment income | 910.0K | 1.5M | ||||
| Interest expense | 729.6K | 541.8K | 1.1M | 781.6K | 2.4M | 10.2M |
| Pre tax profit | (11.5M) | (9.5M) | (11.4M) | (11.5M) | (9.6M) | (15.6M) |
| Net Income | (11.5M) | (9.5M) | (11.4M) | (11.5M) | (9.6M) | (15.6M) |